STOCK TITAN

Simulations Plus to Present at Oppenheimer Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Simulations Plus, Inc. (Nasdaq: SLP) announced that CEO Shawn O’Connor will present at Oppenheimer’s 31st Annual Healthcare Conference on March 16, 2021, at 2:30 p.m. ET. The presentation will be webcast live, and one-on-one meetings will also be conducted with CFO Will Frederick. The accompanying slide presentation will be available on the company's Investors page after the event. For more details about the conference, visit the conference website.

Positive
  • None.
Negative
  • None.

Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn O’Connor, chief executive officer, will be presenting at Oppenheimer’s 31st Annual Healthcare Conference on Tuesday, March 16, 2021. Mr. O’Connor’s presentation, which will be webcast live, will begin at 2:30 p.m. ET. In addition, Mr. O’Connor and chief financial officer Will Frederick will host one-on-one meetings throughout the day.

The Company’s slide presentation will be available on the Investors page of the Simulations Plus website following the presentation. For more information about the Oppenheimer Annual Healthcare Conference, or to register to attend, please visit the conference website.

About Simulations Plus, Inc.

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our vision is to improve health through innovative solutions, and our mission is to create value for our customers by accelerating and reducing the costs of R&D through innovative science-based software and consulting solutions that optimize treatment options and improve patient lives. For more information, please visit our website at www.simulations-plus.com.

FAQ

What is the date and time for Simulations Plus presentation at Oppenheimer’s Healthcare Conference?

Simulations Plus CEO Shawn O’Connor will present on March 16, 2021, at 2:30 p.m. ET.

Where can I watch the Simulations Plus presentation from the Oppenheimer Conference?

The presentation will be webcast live on March 16, 2021, and the slides will be available on the Simulations Plus Investors page after the event.

Who else from Simulations Plus will be attending the Oppenheimer Healthcare Conference?

CFO Will Frederick will also host one-on-one meetings throughout the day.

What is the significance of the Oppenheimer’s Annual Healthcare Conference for SLP?

The conference provides a platform for Simulations Plus to showcase its innovations and engage with investors.

Simulations Plus, Inc.

NASDAQ:SLP

SLP Rankings

SLP Latest News

SLP Stock Data

570.91M
16.42M
18.14%
77.89%
4.88%
Health Information Services
Services-computer Integrated Systems Design
Link
United States of America
LANCASTER